<DOC>
	<DOC>NCT00379067</DOC>
	<brief_summary>Randomized, double-blind, placebo-controlled study with two treatment arms (Tamsulosin OCAS 0.4 mg &amp; placebo). The study comprises a 2-week placebo run-in followed by a 12-week treatment period.</brief_summary>
	<brief_title>A Phase 4 Study With Tamsulosin OCAS to Assess Nighttime Voiding.</brief_title>
	<detailed_description />
	<mesh_term>Hyperplasia</mesh_term>
	<mesh_term>Prostatic Hyperplasia</mesh_term>
	<mesh_term>Lower Urinary Tract Symptoms</mesh_term>
	<mesh_term>Tamsulosin</mesh_term>
	<criteria>Diagnosed as having LUTS associated with BPH On average, at least 2 voids per night over the last week A maximum of 4 hours of undisturbed sleep expected per night (night time is defined as the time from going to bed with the purpose of sleeping until waking up with the purpose of getting up) Subject is currently taking diuretics Subjects who work shift hours and whose hours of work include any time between 23.00 and 06.00h</criteria>
	<gender>Male</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>Benign Prostatic Hyperplasia</keyword>
	<keyword>Nocturia</keyword>
	<keyword>Actigraphy</keyword>
	<keyword>Tamsulosin</keyword>
</DOC>